- $532.91m
- $546.97m
- $36.97m
Clearpoint Neuro Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Clearpoint Neuro Announces Initiation Of Limited Market Release For The Smartframe Or Stereotactic System
Clearpoint Neuro Inc reports results for the quarter ended in December - Earnings Summary
Clearpoint Neuro Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Clearpoint Neuro Announces Pricing Of Public Offering
Brief: Clearpoint Neuro Inc Plans To Commence Limited Market Release In First Half Of 2024
U.S. STOCKS ON THE MOVE-ResMed, Revvity, Acuity Brands
U.S. STOCKS ON THE MOVE-Albemarle, Illumina, Eversource Energy
U.S. STOCKS ON THE MOVE-CrowdStrike, Precision BioSciences, Tilray Brands
U.S. STOCKS ON THE MOVE-Match Group, Unity Software, Clearpoint Neuro
Clearpoint Neuro rises as preliminary quarterly revenue beats estimates
Brief: Clearpoint Neuro Files For Mixed Shelf Of Up To $120 Million
U.S. STOCKS ON THE MOVE-Hologic, Blink Charging, Adobe
ClearPoint falls on FY revenue forecast cut
Clearpoint Neuro Inc reports results for the quarter ended in June - Earnings Summary
Brief: ClearPoint Neuro Sees FY revenue USD 25-27 million
Clearpoint Neuro Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Clearpoint Neuro And UCB Enter License Agreement For Gene Therapy Drug Delivery
Clearpoint Neuro Inc reports results for the quarter ended in March - Earnings Summary